 |
FDA Approval Activities for this Drug
DHE 45 (dihydroergotamine) Injection & Migranal (dihydroergotamine) Nasal Spray, Xcel NDA 20-148/S-007/S-008
005929/S32 & 33 Dihydroergotamine Mesylate Injection, 1 mg/mL, Paddock, ANDA 40-475 4/28/03
Dihydroergotamine Mesylate Injection, 1 mg/mL, Bedford ANDA 40-453 DIHYDROERGOTAMINE MESYLATE Injection 1MG/ML DIHYDROERGOTAMINE MESYLATE Bedford 040475 DIHYDROERGOTAMINE MESYLATE Injection 1MG/ML DIHYDROERGOTTAMINE MESYLATE Paddock
005929 DIHYDROERGOTAMINE MESYLATE Injection 1MG/ML D.H.E. 45 XCEL 020148 DIHYDROERGOTAMINE MESYLATE Spray, Metered; Nasal 0.5MG/INH MIGRANAL XCEL
For the most up-to-date approval information, please locate this API using the drug index.
|